Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective

被引:65
作者
Cheah, Nuan Ping [1 ]
Chong, Norman Wee Lin [2 ]
Tan, Jing [1 ]
Morsed, Faridatul Akmam [1 ]
Yee, Shen Kuan [2 ]
机构
[1] Hlth Sci Author, Appl Sci Grp, Cigarette Testing Lab, Singapore 169078, Singapore
[2] Hlth Sci Author, Tobacco Regulat Branch, Hlth Prod Regulat Grp, Singapore 169078, Singapore
关键词
Electronic nicotine delivery devices; Nicotine; Packaging and Labelling; CIGARETTES; SMOKE;
D O I
10.1136/tobaccocontrol-2012-050483
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective Many electronic nicotine delivery systems (ENDS) are marketed as safer tobacco alternative products or effective cessation therapies. ENDS samples were evaluated for design features, including nicotine and glycols content. This could be useful in developing a legal framework to handle ENDS. Methods Identification of the nicotine, glycerol and propylene glycol (PPG) contents was conducted using gas chromatography mass spectrometry with quantification performed using flame ionisation techniques. Results Varying nicotine amounts were found in ENDS cartridges which were labelled with the same concentration. Chemicals such as PPG and glycerol were found to be present in the nicotine-containing liquid of the cartridges. ENDS varied in their contents and packaging information. Limited information was available on the contents of nicotine and other chemicals present in a variety of ENDS sampled. Conclusions Based on samples tested in this study, many contain misleading information on product ingredients. The results show poor consistency between actual nicotine content analysed on ENDS cartridges and the amount labelled. These findings raise safety and efficacy concerns for current and would-be recreational users or those trying to quit smoking.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 17 条
[1]  
[Anonymous], 2009, FDA warns of health risks posed by e-cigarettes
[2]   Electronic nicotine delivery devices: ineffective nicotine delivery and craving suppression after acute administration [J].
Eissenberg, Thomas .
TOBACCO CONTROL, 2010, 19 (01) :87-88
[3]   Electronic nicotine delivery systems: a research agenda [J].
Etter, Jean-Francois ;
Bullen, Chris ;
Flouris, Andreas D. ;
Laugesen, Murray ;
Eissenberg, Thomas .
TOBACCO CONTROL, 2011, 20 (03) :243-248
[4]  
FDA, 2009, VOIC PUBL HLTH EXP E
[5]  
FDA, 2010, EL CIG
[6]  
Food and Drug Administration (FDA), 2009, SUMM RES LAB AN EL C
[7]   Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives [J].
Foulds, J. ;
Veldheer, S. ;
Berg, A. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (10) :1037-1042
[8]  
Health New Zealand, 2007, RUYAN E CIG
[9]   Electronic nicotine delivery systems: emerging science foundation for policy [J].
Henningfield, J. E. ;
Zaatari, G. S. .
TOBACCO CONTROL, 2010, 19 (02) :89-90
[10]  
International Agency for Research on Cancer, 2006, IARC MONOGRAPHS EVAL, V88